Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03075072 · ClinicalTrials.gov registry record · NA

Hippocampal Sparing Whole Brain Radiation Versus Stereotactic Radiation in Patients With 5-20 Brain Metastases: A Phase III, Randomized Trial

A NA study of Brain Metastases, sponsored by Dana-Farber Cancer Institute.

Active
Registry status
NA
Development phase
196
Enrollment target
2
Study locations

NCT03075072 is a NA study of Brain Metastases that is active but no longer recruiting, run by Dana-Farber Cancer Institute. The registered enrollment target is 196 participants, roughly in line with the 210-participant average among 67 other Brain Metastases trials with a reported enrollment target. The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03075072, a NA study of Brain Metastases, is active but no longer recruiting, sponsored by Dana-Farber Cancer Institute.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
196 participants
Enrollment target
2
Study locations

Study Summary

This research study is studying two different types of radiation as treatment for brain metastases (tumors in the brain that spread from a cancer that originated elsewhere in the body)

Conditions Studied

Brain Metastases

Interventions

  • RADIATION Whole brain radiation
  • RADIATION Stereotactic radiation (SRS)

Study Locations (2)

Massachusetts

  • Brigham and Women's Hospital - Boston
  • Dana Farber Cancer Institute - Boston

Trial Details

FieldValue
Enrollment Target 196 participants
Start Date 2017-04-10
Est. Completion 2025-09-30
Phase NA

Sponsor

Dana-Farber Cancer Institute

781 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03075072

The ClinicalTrials.gov registry entry for NCT03075072 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 196 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 210-participant average among 67 other Brain Metastases trials with a reported enrollment target. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Brain Metastases appearing as the primary indexed condition, and to 2 interventions - of which Whole brain radiation is the first listed.

NCT03075072 reports 2 study locations spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03075072 about?

NCT03075072 is a clinical study titled "Hippocampal Sparing Whole Brain Radiation Versus Stereotactic Radiation in Patients With 5-20 Brain Metastases: A Phase III, Randomized Trial". This research study is studying two different types of radiation as treatment for brain metastases (tumors in the brain that spread from a cancer that originated elsewhere in the body)

What is the current status of trial NCT03075072?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 196 participants. The study started on 2017-04-10. Estimated completion is 2025-09-30.

What conditions does trial NCT03075072 study?

This clinical trial studies the following conditions: Brain Metastases.

What interventions are being tested in trial NCT03075072?

The interventions under investigation include: Whole brain radiation (RADIATION), Stereotactic radiation (SRS) (RADIATION).

Who is sponsoring clinical trial NCT03075072?

This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03075072 being conducted?

This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Brain Metastases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Brain Metastases

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.